18 participants
Pembrolizumab and Axitinib as Neoadjuvant Therapy for Locally Advanced Non-metastatic Clear Cell Renal Cell Carcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-08-06
- Start Date:
- 2021-08-20
- Completion:
- 2022-08-20
Conditions
- Renal Cell Carcinoma
- Clear Cell Renal Cell Carcinoma
Interventions
- DRUG
No Results Yet